Robin Matthews is a Family Nurse Practitioner at Seattle Cancer Care Alliance. Robin graduated from Columbia School of Nursing, in New York, with an M.S. in 2009. Robin has been working with Sickle Cell patients at SCCA since November 2011.
Our last pizza night was held on October 20, 2012 at Round Table Pizza in Federal Way. The discussion topic for the evening was Pain Medication. We had a great group discussion and there were a range of ages present during the night.
Is a chemotherapy agent with a potent effect on the bone marrow. The agent was used for many years to treat people with certain types of cancer. Hydroxyurea is an antineoplastic (cancer fighting) agent available for oral use as capsules to affect certain cells in the body such as cancer cells or sickle red blood cells. It can also be made into a liquid by a compounding pharmacy. Hydroxyurea and blood transfusion are our most powerful treatment options for significant complications in people with Sickle Cell Disease. Hydroxyurea will not cure SCD; however, it has been having surprising results in people with Sickle Cell.
Dr. Bender is a Doctor of Pediatric Oncology and Pediatric Hematology at Odessa Brown’s Children’s Clinic in Seattle. He has been working with Sickle Cell patients for about 15 years.
Sickle Cell Anemia affects over 70,000 people in the U.S. alone. For most people with the disease one consequence is severe pain. If they’re lucky, the pain lasts for a short while, but for many the pain can last for days, weeks, or even longer.